The efficacy and safety of 5 mg/d Vortioxetine compared to placebo for major depressive disorder: A meta-analysis

被引：0
|
作者：
Jie Fu
Yangmei Chen
机构：
[1] The Second Hospital Affiliated of Chongqing Medical University,Department of Neurology
来源：
Psychopharmacology | 2015年 / 232卷
关键词：
Vortioxetine; Placebo; Major depressive disorder; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 16
页数：9
相关论文
共 50 条
  • [1] The efficacy and safety of 5 mg/d Vortioxetine compared to placebo for major depressive disorder: A meta-analysis
    Fu, Jie
    Chen, Yangmei
    [J]. PSYCHOPHARMACOLOGY, 2015, 232 (01) : 7 - 16
  • [2] The efficacy and safety of 10 mg/day vortioxetine compared to placebo for adult major depressive disorder: a meta-analysis
    Zheng, Jiahuan
    Wang, Zhaoyu
    Li, Enli
    [J]. AFRICAN HEALTH SCIENCES, 2019, 19 (01) : 1716 - 1726
  • [3] Comment on Fu, J. and Chen, Y.: The efficacy and safety of 5 mg/d vortioxetine compared to placebo for major depressive disorder: a meta-analysis
    Humes, Eduardo C.
    Brunoni, Andre R.
    [J]. PSYCHOPHARMACOLOGY, 2017, 234 (05) : 903 - 904
  • [4] Comment on Fu, J. and Chen, Y.: The efficacy and safety of 5 mg/d vortioxetine compared to placebo for major depressive disorder: a meta-analysis
    Eduardo C. Humes
    Andre R. Brunoni
    [J]. Psychopharmacology, 2017, 234 : 903 - 904
  • [5] The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
    Li, Guangjian
    Wang, Xu
    Ma, Dihui
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 523 - 531
  • [6] Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder
    Montgomery, Stuart A.
    Feighner, John P.
    Sverdlov, Lev
    Shrivastava, Ram K.
    Cunningham, Lynn A.
    Kiev, Ari
    Hlavka, Joseph
    Tonelli, George, Jr.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 (05): : 517 - 528
  • [7] The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: A systematic review and meta-analysis
    Meeker A.S.
    Herink M.C.
    Haxby D.G.
    Hartung D.M.
    [J]. Systematic Reviews, 4 (1)
  • [8] A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
    Thase, Michael E.
    Mahableshwarkar, Atul R.
    Dragheim, Marianne
    Loft, Henrik
    Vieta, Eduard
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (06) : 979 - 993
  • [9] Efficacy and safety of zuranolone in the treatment of major depressive disorder: a meta-analysis
    Wang, Shuyu
    Zhang, Wenxing
    Liu, Zhang
    Zhang, Tian
    Wang, Yi
    Li, Weihong
    [J]. FRONTIERS IN NEUROSCIENCE, 2024, 17
  • [10] The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis.
    Meeker, Amanda
    Hartung, Daniel
    Herink, Megan
    Haxby, Dean
    [J]. PHARMACOTHERAPY, 2014, 34 (10): : E262 - E262
12345